Zikani Therapeutics has a total of 40 patents globally, out of which 2 have been granted. Of these 40 patents, more than 92% patents are active. United States of America is where Zikani Therapeutics has filed the maximum number of patents, followed by Australia and Singapore. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Zikani Therapeutics.
Zikani Therapeutics was founded in the year 2014. The Company operates in the healthcare sector focusing on pharmaceutical business.
Do read about some of the most popular patents of Zikani Therapeutics which have been covered by us in this article and also you can find Zikani Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Zikani Therapeutics patent portfolio.
How many patents does Zikani Therapeutics have?
Zikani Therapeutics has a total of 40 patents globally. These patents belong to 6 unique patent families. Out of 40 patents, 37 patents are active.
How Many Patents did Zikani Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Zikani Therapeutics Applications Filed | Zikani Therapeutics Patents Granted |
| 2023 | 4 | 2 |
| 2022 | 4 | – |
| 2021 | 8 | – |
| 2019 | 23 | – |
| 2018 | 1 | – |
How many Zikani Therapeutics patents are Alive/Dead?
How Many Patents did Zikani Therapeutics File in Different Countries?
Countries in which Zikani Therapeutics Filed Patents
| Country | Patents |
| United States of America | 4 |
| Australia | 3 |
| Singapore | 3 |
| Eurasia | 2 |
| India | 2 |
| China | 2 |
| Europe | 2 |
| Japan | 2 |
| Mexico | 2 |
| Canada | 2 |
| Brazil | 2 |
| South Africa | 2 |
| Hong Kong (S.A.R.) | 2 |
| Indonesia | 2 |
| Israel | 2 |
| Taiwan | 1 |
Where are Research Centres of Zikani Therapeutics Patents Located?
The Research Centre for all the Zikani Therapeutics patents is the United States of America.
What Percentage of Zikani Therapeutics US Patent Applications were Granted?
Zikani Therapeutics (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Zikani Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Zikani Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Jonathan P O Brien Ph D | 1 | 100.00% |
List of Zikani Therapeutics Patents
| Zikani Therapeutics Patents | Title |
| US11673910B2 | Macrolides With Modified Desosamine Sugars And Uses Thereof |
| US20230242565A1 | Macrolides With Modified Desosamine Sugars And Uses Thereof |
| US20230093692A1 | C10-Alkylene Substituted 13-Membered Macrolides And Uses Thereof |
| US20220177508A1 | C10-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| EP3883647A1 | C10-Alkylene Substituted 13-Membered Macrolides And Uses Thereof |
| EP3883945A1 | C11-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| CN113646319A | C11-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| CN113573779A | C10-Alkylene Substituted 13-Membered Macrolides And Uses Thereof |
| AU2019385383B2 | C10-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| WO2023250513A1 | 13-Membered Macrolide Compounds For Treating Diseases Mediated By Abnormal Protein Translation |
| WO2023235380A1 | Macrolides For Treating Genetic Diseases |
| AU2023229518A1 | C10-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| SG10202300592VA | C10-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| AU2019385333A1 | C10-Alkylene Substituted 13-Membered Macrolides And Uses Thereof |
| SG11202105228SA | C10-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| SG11202105227QA | C10-Alkylene Substituted 13-Membered Macrolides And Uses Thereof |
| JP2022507795A5 | C10 Cyclically Substituted 13-Membered Macrolides And Their Uses |
| JP2022507776A5 | C10-Alkylene Substituted 13-Membered Macrolides And Their Uses |
| HK40063711A | C11-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| HK40063248A | C10-Alkylene Substituted 13-Membered Macrolides And Uses Thereof |
| EA202191410A1 | C10-Cyclic Substituted 13-Member Macrolides And Their Use |
| EA202191409A1 | C10-Alkylene-Substituted 13-Member Macrolides And Their Applications |
| IN202117027299A | C11-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| IN202117027061A | C10-Alkylene Substituted 13-Membered Macrolides And Uses Thereof |
| ID2021PID08216A | C10-Cycic Substituted 13 Member Macrolides And Their Uses |
| ID2021PID07962A | C10-Alkylene Substituted 13 Member Macrolides And Its Uses |
| MX2021005421A | C11-Cyclic Substituted 13-Membered Macrolides And Uses Thereof. |
| MX2021005423A | C10-Alkylene Substituted 13-Membered Macrolides And Uses Thereof. |
| BR112021009607A2 | C10-Cyclic Substituted 13-Mem Macrolides And Uses Thereof |
| BR112021009624A2 | Macrolides With 13 Members Replaced By C10- Alkylene And Uses Thereof |
| IL283194A0 | C10-Alkylene Substituted 13-Membered Macrolides And Uses Thereof |
| IL283185A0 | C10-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| ZA202103084A | C10-Alkylene Substituted 13-Membered Macrolides And Uses Thereof |
| ZA202103087A | C10-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| CA3120148A1 | C10-Alkylene Substituted 13-Membered Macrolides And Uses Thereof |
| CA3120235A1 | C11-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| TW202313065A | Compounds For Treating Genetic Diseases |
| WO2022251730A1 | Compounds For Treating Genetic Diseases |
| WO2020106636A1 | C11-Cyclic Substituted 13-Membered Macrolides And Uses Thereof |
| WO2020106627A1 | C10-Alkylene Substituted 13-Membered Macrolides And Uses Thereof |
What Technologies are Covered by Zikani Therapeutics?
The chart below distributes patents filed by Zikani Therapeutics